0001493152-26-039295.txt : 20260820 0001493152-26-039295.hdr.sgml : 20260820 20260819203100 ACCESSION NUMBER: 0001493152-26-039295 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering FILED AS OF DATE: 20260820 DATE AS OF CHANGE: 20260819 EFFECTIVENESS DATE: 20260820 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Dare Bioscience, Inc. CENTRAL INDEX KEY: 0001401914 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences EIN: 204139823 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-594815 FILM NUMBER: 261296961 BUSINESS ADDRESS: STREET 1: 3655 NOBEL DRIVE STREET 2: SUITE 260 CITY: SAN DIEGO STATE: CA ZIP: 92122 BUSINESS PHONE: 858-926-7655 MAIL ADDRESS: STREET 1: 3655 NOBEL DRIVE STREET 2: SUITE 260 CITY: SAN DIEGO STATE: CA ZIP: 92122 FORMER COMPANY: FORMER CONFORMED NAME: Cerulean Pharma Inc. DATE OF NAME CHANGE: 20090714 FORMER COMPANY: FORMER CONFORMED NAME: Tempo Pharmaceuticals Inc DATE OF NAME CHANGE: 20070604 D 1 primary_doc.xml X0708 D LIVE 0001401914 Dare Bioscience, Inc. 3655 NOBEL DRIVE SUITE 260 SAN DIEGO CA CALIFORNIA 92122 858-926-7655 DELAWARE None Cerulean Pharma Inc. Tempo Pharmaceuticals Inc Corporation true Sabrina Martucci Johnson 3655 Nobel Drive Suite 260 San Diego CA CALIFORNIA 92122 Executive Officer Director President and Chief Executive Officer MarDee Haring-Layton 3655 Nobel Drive Suite 260 San Diego CA CALIFORNIA 92122 Executive Officer Chief Accounting Officer William H. Rastetter 3655 Nobel Drive Suite 260 San Diego CA CALIFORNIA 92122 Director Jessica D. Grossman 3655 Nobel Drive Suite 260 San Diego CA CALIFORNIA 92122 Director Susan L. Kelley 3655 Nobel Drive Suite 260 San Diego CA CALIFORNIA 92122 Director Gregory W. Matz 3655 Nobel Drive Suite 260 San Diego CA CALIFORNIA 92122 Director Robin J. Steele 3655 Nobel Drive Suite 260 San Diego CA CALIFORNIA 92122 Director Biotechnology Decline to Disclose 06b false 2026-08-17 false true true false 0 Ladenburg Thalmann & Co. Inc. 000000505 Ladenburg Thalmann & Co. Inc. 000000505 640 Fifth Avenue, 4th Floor New York NY NEW YORK 10019 All States false 12375054 12375054 0 The total offering amount reflects proceeds if all warrants, consisting of 8,759,162 and 175,183 shares of common stock exercisable at $1.37 and $2.1235 per share, respectively, are exercised for cash. No warrants have been exercised as of this filing. false 12 0 0 0 false Dare Bioscience, Inc. /s/ MarDee Haring-Layton MarDee Haring-Layton Chief Accounting Officer 2026-08-19